Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval for SYMPAZAN(TM) (clobazam) Oral Film

SYMPAZAN is the first and only FDA-approved oral film formulation of clobazam, a benzodiazepine approved for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older(1) SYMPAZAN is delivered via ... Biopharmaceuticals, Drug Delivery, FDA Aquestive Therapeutics, SYMPAZAN, clobazam, PharmFilm
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news